Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 6.49x is 43% above its estimated 1-year average of 4.53x, around the middle of its estimated 1-year range (0.70x–12.34x).
As of 2026-10-06T18:28:05.675Z.
Calculation as of: 2026-10-06T18:28:05.675Z.
Quote observation: 2026-10-06T18:25:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e871ea8067f28394f736e732b3966b53b535a0e4ae5ed833c49956b30cd07697
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
6.49x
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
22.77x
median of 197 covered companies
CURRENT VS SECTOR MEDIAN
-71.50%
vs the sector median at left
Market Cap
$242.12M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.49M
EV/EBIT Ratio
N/A
TTM Avg
98.16x
3Y Avg
1055.07x
5Y Avg
378.93x
Market Cap
$237.69M
EV/EBIT Ratio
99.44x
TTM Avg
177.33x
3Y Avg
172.45x
5Y Avg
172.45x
Market Cap
$237.27M
EV/EBIT Ratio
N/A
TTM Avg
245.87x
3Y Avg
245.87x
5Y Avg
245.87x
Market Cap
$236.67M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.97M
EV/EBIT Ratio
22.98x
TTM Avg
12.07x
3Y Avg
10.11x
5Y Avg
11.81x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $240.16M | 6.49x | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $238.81M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.12M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.49M | N/A | 98.16x | 1055.07x | 378.93x |
| High Tide Inc. (HITI)vs › | $237.69M | 99.44x | 177.33x | 172.45x | 172.45x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.27M | N/A | 245.87x | 245.87x | 245.87x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $236.67M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.97M | 22.98x | 12.07x | 10.11x | 11.81x |
| Quantum-Si incorporated (QSI)vs › | $245.30M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-10-05 | 0.79x |
| 2026-10-02 | 0.70x |
| 2026-10-01 | 0.71x |
| 2026-09-30 | 0.73x |
| 2026-09-29 | 1.55x |
| 2026-09-28 | 1.36x |
| 2026-09-25 | 1.05x |
| 2026-09-24 | 1.35x |
| 2026-09-23 | 1.57x |
| 2026-09-22 | 2.24x |
| 2026-09-21 | 2.17x |
| 2026-09-18 | 2.22x |
| 2026-09-17 | 2.43x |
| 2026-09-16 | 2.51x |
| 2026-09-15 | 2.63x |
| 2026-09-14 | 2.46x |
| 2026-09-11 | 2.59x |
| 2026-09-10 | 2.34x |
| 2026-09-09 | 2.61x |
| 2026-09-08 | 2.97x |
| 2026-09-04 | 3.17x |
| 2026-09-03 | 3.70x |
| 2026-09-02 | 4.22x |
| 2026-09-01 | 4.73x |
| 2026-08-31 | 5.06x |
| 2026-08-28 | 5.17x |
| 2026-08-27 | 5.90x |
| 2026-08-26 | 5.92x |
| 2026-08-25 | 6.01x |
| 2026-08-24 | 6.04x |
| 2026-08-21 | 5.78x |
| 2026-08-20 | 5.71x |
| 2026-08-19 | 5.70x |
| 2026-08-18 | 5.34x |
| 2026-08-17 | 5.77x |
| 2026-08-14 | 5.25x |
| 2026-08-13 | 5.39x |
| 2026-08-12 | 5.39x |
| 2026-08-11 | 5.42x |
| 2026-08-10 | 5.59x |
| 2026-08-07 | 5.54x |
| 2026-08-06 | 5.93x |
| 2026-08-05 | 9.12x |
| 2026-08-04 | 8.91x |
| 2026-08-03 | 8.25x |
| 2026-07-31 | 8.59x |
| 2026-07-30 | 8.51x |
| 2026-07-29 | 7.91x |
| 2026-07-28 | 8.61x |
| 2026-07-27 | 8.28x |
| 2026-07-24 | 8.24x |
| 2026-07-23 | 8.39x |
| 2026-07-22 | 8.20x |
| 2026-07-21 | 8.41x |
| 2026-07-20 | 8.17x |
| 2026-07-17 | 8.18x |
| 2026-07-16 | 8.28x |
| 2026-07-15 | 8.60x |
| 2026-07-14 | 10.42x |
| 2026-07-13 | 12.34x |
| 2026-07-10 | 5.65x |
| 2026-07-09 | 6.56x |
| 2026-07-08 | 7.54x |
| 2026-07-07 | 7.23x |
| 2026-07-06 | 6.74x |
| 2026-07-02 | 6.89x |
| 2026-07-01 | 6.56x |
| 2026-06-30 | 6.65x |
| 2026-06-29 | 7.58x |
| 2026-06-26 | 6.94x |
| 2026-06-25 | 6.13x |
| 2026-06-24 | 5.61x |
| 2026-06-23 | 6.09x |
| 2026-06-22 | 6.60x |
| 2026-06-18 | 6.10x |
| 2026-06-17 | 6.77x |
| 2026-06-16 | 6.66x |
| 2026-06-15 | 6.73x |
| 2026-06-12 | 6.59x |
| 2026-06-11 | 6.63x |
| 2026-06-10 | 6.74x |
| 2026-06-09 | 6.10x |
| 2026-06-08 | 6.19x |
| 2026-06-05 | 6.90x |
| 2026-06-04 | 7.48x |
| 2026-06-03 | 6.29x |
| 2026-06-02 | 6.59x |
| 2026-06-01 | 5.94x |
| 2026-05-29 | 5.54x |
| 2026-05-28 | 5.05x |
| 2026-05-27 | 6.73x |
| 2026-05-26 | 2.93x |
| 2026-05-22 | 2.09x |
| 2026-05-21 | 1.89x |
| 2026-05-20 | 2.00x |
| 2026-05-19 | 2.26x |
| 2026-05-18 | 2.05x |
| 2026-05-15 | 2.41x |
| 2026-05-14 | 2.38x |
| 2026-05-13 | 2.18x |
| 2026-05-12 | 2.09x |
| 2026-05-11 | 1.68x |
| 2026-05-08 | 1.80x |
| 2026-05-07 | 1.85x |
| 2026-05-06 | 1.87x |
| 2026-05-05 | 2.07x |
| 2026-05-04 | 1.99x |
| 2026-05-01 | 1.99x |
| 2026-04-30 | 2.43x |
| 2026-04-29 | 2.35x |
| 2026-04-28 | 2.52x |
| 2026-04-27 | 2.32x |
| 2026-04-24 | 2.91x |
| 2026-04-23 | 3.11x |
| 2026-04-22 | 3.25x |
| 2026-04-21 | 3.07x |
| 2026-04-20 | 3.25x |
| 2026-04-17 | 2.62x |
| 2026-04-16 | 2.52x |
| 2026-04-15 | 2.81x |
| 2026-04-14 | 2.64x |
| 2026-04-13 | 2.28x |
| 2026-04-10 | 2.00x |
| 2026-04-09 | 1.89x |
| 2026-04-08 | 2.32x |
| 2026-04-07 | 2.66x |
| 2026-04-06 | 2.46x |
| 2026-04-02 | 3.03x |
| 2026-04-01 | 2.82x |
| 2026-03-31 | 3.07x |
| 2026-03-30 | 2.66x |
| 2026-03-27 | 3.71x |
| 2026-03-26 | 3.63x |
| 2026-03-25 | 3.71x |
| 2026-03-24 | 3.75x |
| 2026-03-23 | 3.33x |
| 2026-03-20 | 3.27x |
| 2026-03-19 | 3.26x |
| 2026-03-18 | 2.59x |
| 2026-03-17 | 2.84x |
| 2026-03-16 | 2.97x |
| 2026-03-13 | 3.38x |
| 2026-03-12 | 3.55x |
| 2026-03-11 | 3.45x |
